Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $7.00 target price on the stock. Several other brokerages also recently commented on ANIX. D. Boral Capital reiterated a “buy” rating and set a $10.00 price target […]
More Stories
Federal Reserve Keeps Interest Rates Unchanged, Signals 2 Cuts This year
By Andrew Moran The Federal Reserve kept interest rates unchanged for the fourth straight meeting on June 18, a decision...
Trust Point Inc. Cuts Position in The Boeing Company (NYSE:BA)
Trust Point Inc. decreased its position in The Boeing Company (NYSE:BA – Free Report) by 15.4% during the first quarter,...
Prime Day Just Got Even Better With Amazon’s Exciting Free Game Offers
Ahead of the long-awaited Prime Day 2025, Amazon has already started offering a surprise to its Prime Members – free...
Exchange Traded Concepts LLC Reduces Position in Merck & Co., Inc. (NYSE:MRK)
Exchange Traded Concepts LLC decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 74.8%...
Capital One Shopping Review: Save More While You Shop Online
In this digital shopping era, getting your hands on the best deals can be a little time-consuming, but not for...
Top Electric Vehicle Stocks To Follow Today – June 15th
Tesla, Shell, Rivian Automotive, Navitas Semiconductor, and Enphase Energy are the five Electric Vehicle stocks to watch today, according to...